Who owns LEAP THERAPEUTICS INC?
- Ticker: CYPH
- CUSIP Number: 52187k200
Tip: Access positions for across all investors
Analyze quarterly positions in Leap Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Leap Therapeutics stock
Who bought or sold LEAP THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Gilead Sciences | 5.3M | $2.4M | 0% | Sep 2025 |
|
| Vanguard Group | 2.1M | $2.5M | 83% | Dec 2025 |
|
| HighTower Advisors | 1.1M | $502k | 1% | Sep 2025 |
|
| Simplify Asset Management | 976k | $443k | 14% | Sep 2025 |
|
| Geode Capital Management | 530k | $615k | 70% | Dec 2025 |
|
| Jane Street | 165k | $75k | 100% | Sep 2025 |
|
| State Street Corporation | 140k | $163k | 12% | Dec 2025 |
|
| BlackRock | 125k | $57k | 0% | Sep 2025 |
|
| Hrt Financial | 119k | $53k | 100% | Sep 2025 |
|
| Texas Capital Bank Wealth Management Services | 104k | $121k | 100% | Dec 2025 |
|
| Two Sigma Advisers | 100k | $45k | 141% | Sep 2025 |
|
| Susquehanna International | 98k | $45k | 60% | Sep 2025 |
|
| Key Client Fiduciary Advisors | 85k | $98k | -39% | Dec 2025 |
|
| Citadel Advisors | 71k | $32k | -36% | Sep 2025 |
|
| Two Sigma Investments | 71k | $32k | 410% | Sep 2025 |
|
| Northern Trust | 62k | $28k | 0% | Sep 2025 |
|
| LPL Financial | 36k | $16k | -17% | Sep 2025 |
|
| UBS Group | 31k | $36k | 7686% | Dec 2025 |
|
| XTX Topco | 31k | $14k | 119% | Sep 2025 |
|
| ADAR1 Capital Management | 26k | $12k | -35% | Sep 2025 |
|
| Baird Financial | 20k | $9.1k | 0% | Sep 2025 |
|
| Keystone Financial Group | 12k | $14k | 100% | Dec 2025 |
|
| William Blair $ Company | 10k | $4.5k | 0% | Sep 2025 |
|
| Simplex Trading | 5.0k | $2.0k | -2% | Sep 2025 |
|
| CNB Bank | 5.0k | $2.3k | 0% | Sep 2025 |
|
| Group One Trading | 3.8k | $1.7k | 0% | Sep 2025 |
|
| Farther Finance Advisors | 2.1k | $2.4k | 106% | Dec 2025 |
|
| Advisor Group Holdings | 1.9k | $526.019000 | 0% | Sep 2025 |
|
| Huntington National Bank | 1.0k | $1.2k | 0% | Dec 2025 |
|
| Optima Capital | 798.00 | $925.999200 | 100% | Dec 2025 |
|
| Jpmorgan Chase & Co | 227.00 | $102.989900 | 100% | Sep 2025 |
|
| Fortitude Family Office | 182.00 | $210.992600 | 100% | Dec 2025 |
|
| Hanson McClain Advisors | 135.00 | $62.005500 | 0% | Sep 2025 |
|
| Royal Bank of Canada | 130.00 | $0 | 30% | Sep 2025 |
|
| Tompkins Financial Corp | 120.00 | $138.996000 | 0% | Dec 2025 |
|
Who sold out of Leap Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| 683 Capital Management | Jun 2025 | 1.4M | $429k |
| Acadian Asset Management | Sep 2025 | 1.2M | $560k |
| Dauntless Investment Group | Jun 2025 | 60k | $18k |
| Virtu Financial | Jun 2025 | 40k | $12k |
| DRW Holdings | Jun 2025 | 28k | $8.4k |
| Raymond James Financial | Jun 2025 | 4.6k | $1.4k |
| Atlantic Trust | Jun 2025 | 1.5k | $445.050000 |